Who owns Array BioPharma?

Key details on Array BioPharma (Ticker: ARRY)

Who owns Array BioPharma?

Is ARRY a good stock to own? Find out who bought Array BioPharma, who sold Array BioPharma (ARRY) stock, and who holds a large position in Array BioPharma.

Fund Name Number of Shares Share Valuation As Of
BVF 14.72M $67.10M June 30, 2014
FMR 12.47M $58.60M March 31, 2014
Deerfield Management Company 12.21M $55.66M June 30, 2014
T. Rowe Price Associates 8.87M $40.47M June 30, 2014
Redmile 8.09M $36.87M June 30, 2014
OrbiMed Advisors 6.40M $29.20M June 30, 2014
STATE STREET CORPORATION 5.26M $23.99M June 30, 2014
BlackRock Fund Advisors 4.65M $21.19M June 30, 2014
Vanguard 3.94M $17.98M June 30, 2014
TimesSquare Capital Management 3.87M $17.67M June 30, 2014
BlackRock Institutional Trust Company, N.A. 3.74M $17.05M June 30, 2014
Apex Capital 3.60M $16.42M June 30, 2014
Artal Group S.A. 3.00M $13.68M June 30, 2014
Gail Mannix 2.85M $13.40M March 31, 2014
GMT Capital 2.31M $14.38M Sept. 30, 2013
KOPP FUNDS 2.23M $11.17M Dec. 31, 2013
QVT Financial 2.10M $9.56M June 30, 2014
Balyasny Asset Management 2.07M $9.73M March 31, 2014
Kopp Investment Advisors 2.01M $9.17M June 30, 2014
Ulys 2.00M $6.80M March 31, 2012
Perceptive Advisors 1.93M $4.17M Dec. 31, 2011
Ridgeback Capital Investments 1.91M $11.16M Sept. 30, 2012
Perimeter Capital Partners 1.83M $6.79M Dec. 31, 2012
Cormorant Asset Management 1.75M $8.22M March 31, 2014
NORTHERN TRUST 1.74M $8.71M Dec. 31, 2013
Sectoral Asset Management 1.72M $5.96M June 30, 2012
BlackRock Advisors 1.71M $8.04M March 31, 2014

Who sold Array BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management June 30, 2011 4.40M $9.85M
Wellington Management Company June 30, 2011 1.78M $4.00M